151 related articles for article (PubMed ID: 34662891)
21. VPREB1 deletions occur independent of lambda light chain rearrangement in childhood acute lymphoblastic leukemia.
Mangum DS; Downie J; Mason CC; Jahromi MS; Joshi D; Rodic V; Müschen M; Meeker N; Trede N; Frazer JK; Zhou Y; Cheng C; Jeha S; Pui CH; Willman CL; Harvey RC; Hunger SP; Yang JJ; Barnette P; Mullighan CG; Miles RR; Schiffman JD
Leukemia; 2014 Jan; 28(1):216-20. PubMed ID: 23881307
[No Abstract] [Full Text] [Related]
22. Conventional and surrogate light chains differentially regulate Ig mu and Dmu heavy chain maturation and surface expression.
Fang T; Smith BP; Roman CA
J Immunol; 2001 Oct; 167(7):3846-57. PubMed ID: 11564802
[TBL] [Abstract][Full Text] [Related]
23. Emergence of a B-cell lymphoblastic lymphoma in a patient with B-cell chronic lymphocytic leukemia: evidence for the single-cell origin of the two tumors.
Pistoia V; Roncella S; Di Celle PF; Sessarego M; Cutrona G; Cerruti G; Boccaccio GP; Grossi CE; Foà R; Ferrarini M
Blood; 1991 Aug; 78(3):797-804. PubMed ID: 1859892
[TBL] [Abstract][Full Text] [Related]
24. Analysis of VpreB expression during B lineage differentiation in lambda5-deficient mice.
Stephan RP; Elgavish E; Karasuyama H; Kubagawa H; Cooper MD
J Immunol; 2001 Oct; 167(7):3734-9. PubMed ID: 11564789
[TBL] [Abstract][Full Text] [Related]
25. Lymphoblastic lymphoma.
Cortelazzo S; Ponzoni M; Ferreri AJ; Hoelzer D
Crit Rev Oncol Hematol; 2011 Sep; 79(3):330-43. PubMed ID: 21273093
[TBL] [Abstract][Full Text] [Related]
26. Minimal residual disease detection in childhood precursor-B-cell acute lymphoblastic leukemia: relation to other risk factors. A Children's Oncology Group study.
Borowitz MJ; Pullen DJ; Shuster JJ; Viswanatha D; Montgomery K; Willman CL; Camitta B;
Leukemia; 2003 Aug; 17(8):1566-72. PubMed ID: 12886244
[TBL] [Abstract][Full Text] [Related]
27. A truncated heavy chain protein relieves the requirement for surrogate light chains in early B cell development.
Shaffer AL; Schlissel MS
J Immunol; 1997 Aug; 159(3):1265-75. PubMed ID: 9233622
[TBL] [Abstract][Full Text] [Related]
28. Only VpreB1, but not VpreB2, is expressed at levels which allow normal development of B cells.
Mundt C; Licence S; Maxwell G; Melchers F; Mårtensson IL
Int Immunol; 2006 Jan; 18(1):163-72. PubMed ID: 16361315
[TBL] [Abstract][Full Text] [Related]
29. [Minimal residual disease monitoring by flow cytometry in children with acute lymphoblastic leukemia].
Popov AM; Verzhbitskaia TIu; Tsaur GA; Shorikov EV; Savel'ev LI; Tsvirenko SV; Fechina LG
Klin Lab Diagn; 2010 Aug; (8):36-41. PubMed ID: 20886718
[TBL] [Abstract][Full Text] [Related]
30. Overexpression of CD49f in precursor B-cell acute lymphoblastic leukemia: potential usefulness in minimal residual disease detection.
DiGiuseppe JA; Fuller SG; Borowitz MJ
Cytometry B Clin Cytom; 2009 Mar; 76(2):150-5. PubMed ID: 18831072
[TBL] [Abstract][Full Text] [Related]
31. The pre-B-cell receptor associated protein VpreB3 is a useful diagnostic marker for identifying c-MYC translocated lymphomas.
Rodig SJ; Kutok JL; Paterson JC; Nitta H; Zhang W; Chapuy B; Tumwine LK; Montes-Moreno S; Agostinelli C; Johnson NA; Ben-Neriah S; Farinha P; Shipp MA; Piris MA; Grogan TM; Pileri SA; Gascoyne RD; Marafioti T
Haematologica; 2010 Dec; 95(12):2056-62. PubMed ID: 20823132
[TBL] [Abstract][Full Text] [Related]
32. Inflammatory immune cells may impair the preBCR checkpoint, reduce new B cell production, and alter the antibody repertoire in old age.
Riley RL; Khomtchouk K; Blomberg BB
Exp Gerontol; 2018 May; 105():87-93. PubMed ID: 29408522
[TBL] [Abstract][Full Text] [Related]
33. B-Lymphoblastic Lymphomas Evolving from Follicular Lymphomas Co-Express Surrogate Light Chains and Mutated Gamma Heavy Chains.
Slot LM; Hoogeboom R; Smit LA; Wormhoudt TA; Biemond BJ; Oud ME; Schilder-Tol EJ; Mulder AB; Jongejan A; van Kampen AH; Kluin PM; Guikema JE; Bende RJ; van Noesel CJ
Am J Pathol; 2016 Dec; 186(12):3273-3284. PubMed ID: 27750045
[TBL] [Abstract][Full Text] [Related]
34. Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukemia with medium risk features. A case control study of the International BFM study group.
Biondi A; Valsecchi MG; Seriu T; D'Aniello E; Willemse MJ; Fasching K; Pannunzio A; Gadner H; Schrappe M; Kamps WA; Bartram CR; van Dongen JJ; Panzer-Grümayer ER
Leukemia; 2000 Nov; 14(11):1939-43. PubMed ID: 11069029
[TBL] [Abstract][Full Text] [Related]
35. Intrachromosomal amplification of chromosome 21 is associated with inferior outcomes in children with acute lymphoblastic leukemia treated in contemporary standard-risk children's oncology group studies: a report from the children's oncology group.
Heerema NA; Carroll AJ; Devidas M; Loh ML; Borowitz MJ; Gastier-Foster JM; Larsen EC; Mattano LA; Maloney KW; Willman CL; Wood BL; Winick NJ; Carroll WL; Hunger SP; Raetz EA
J Clin Oncol; 2013 Sep; 31(27):3397-402. PubMed ID: 23940221
[TBL] [Abstract][Full Text] [Related]
36. The VpreB protein of the surrogate light-chain can pair with some mu heavy-chains in the absence of the lambda 5 protein.
Seidl T; Rolink A; Melchers F
Eur J Immunol; 2001 Jul; 31(7):1999-2006. PubMed ID: 11449352
[TBL] [Abstract][Full Text] [Related]
37. Charged Amino Acid-rich Leucine Zipper-1 (Crlz-1) as a Target of Wnt Signaling Pathway Controls Pre-B Cell Proliferation by Affecting Runx/CBFβ-targeted VpreB and λ5 Genes.
Choi SY; Park SK; Yoo HW; Pi JH; Kang CJ
J Biol Chem; 2016 Jul; 291(29):15008-19. PubMed ID: 27226553
[TBL] [Abstract][Full Text] [Related]
38. Repertoire selection by pre-B-cell receptors and B-cell receptors, and genetic control of B-cell development from immature to mature B cells.
Melchers F; ten Boekel E; Seidl T; Kong XC; Yamagami T; Onishi K; Shimizu T; Rolink AG; Andersson J
Immunol Rev; 2000 Jun; 175():33-46. PubMed ID: 10933589
[TBL] [Abstract][Full Text] [Related]
39. The VpreB1 enhancer drives developmental stage-specific gene expression in vivo.
Licence S; Persson C; Mundt C; Mårtensson IL
Eur J Immunol; 2003 Apr; 33(4):1117-26. PubMed ID: 12672078
[TBL] [Abstract][Full Text] [Related]
40. The unique region of surrogate light chain component lambda5 is a heavy chain-specific regulator of precursor B cell receptor signaling.
Guloglu FB; Bajor E; Smith BP; Roman CA
J Immunol; 2005 Jul; 175(1):358-66. PubMed ID: 15972669
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
